2021

Oct 21

Notice Regarding the Opinion on the Tender Offer from Shinsei Bank, Limited. (Securities Code: 8303) and Procedures for Convocation of the Shareholders Meeting to Confirm Shareholders’ Intent

(154.2 KB)

Oct 12

Results of A First-in-Human Study for New Application of Photodynamic Therapy with 5-Aminolevulinic Acid for Extracorporeal Photopheresis Published in “Pharmaceutics”

(167.7 KB)

Oct 11

Notice Regarding the Forecast of the Consolidated Profit Before Income Tax Expense For the Six Months Ended September 30, 2021

(132.0 KB)

Oct 8

Notice Regarding the Application for Listing of SBI Sumishin Net Bank, Ltd.

(185.7 KB)

Oct 1

Notice Regarding Response from Shinsei Bank, Limited. (Securities Code: 8303) to the Questions from the SBIHD Parties

(125.6 KB)

Sep 29

Notice of the Extension of the Tender Offer Period to Shinsei Bank, Limited. (Securities Code: 8303)

(146.3 KB)

Sep 28

Notice Regarding Our Response to “Questions to SBI Holdings and SBI Regional Bank Holdings” from Shinsei Bank, Limited. (Securities Code: 8303)

(527.6 KB)

Sep 24

Notice Regarding Our Response to “Request for Extension of End Date of Tender Offer Period” from Shinsei Bank, Limited. (Securities Code: 8303)

(227.5 KB)

Sep 9

Notice Regarding Commencement of a Tender Offer for the Shares of Shinsei Bank, Limited (Securities Code: 8303)

(480.4 KB)

Sep 7

Photonamic GmbH & Co. KG (Germany) Enrolls First Patient in Phase 2 Clinical Trial of PD L 506 (5-ALA HCl) for Interstitial Photodynamic Therapy (iPDT) of Glioblastoma

(243.3 KB)

Aug 13

Notice of the Completion of SBI Capital’s Registration as a New Technology Venture Capital Company

(171.6 KB)

Aug 11

Notice Regarding the Launch of a DLT-based Money Transfer Service between Korea and Thailand -Cooperating with Global Money Express Co., Ltd., a Major Korean Funds Transfer Service Provider-

(164.2 KB)

Jul 19

Results of Phase II Trial for Breast Cancer Surgery Published in Breast Cancer Research

(215.9 KB)

Jul 19

Research Article on Treatment with 5-Aminolevulinic Acid Phosphate for Patients with New Coronavirus Infection (COVID-19) Published in the International Academic Journal “The Open COVID Journal” Specialized in COVID-19

(131.6 KB)

Jul 7

Notice Regarding Investment in AND Global, a Fintech Startup Originally from Mongolia

(159.3 KB)

Jul 7

SBI Biotech’s Licensed product, an Anti-ILT7 antibody (HZN-7734) has achieved a Developmental Milestone in a Phase 2 Clinical Trial

(99.7 KB)

May 12

Notice of Joint Establishment of a Private Fund By FUJITEC and SBI Investment

(171 KB)

May 7

SBI ALApharma Canada Inc., a Subsidiary of photonamic GmbH & Co. KG (Germany), Enrolls First Patient in Pivotal Phase 3 Clinical Trial of PD G 506 A (5-ALA HCl) and Eagle Fluorescence Imaging SystemTM for Breast Conserving Surgery

(171 KB)

Apr 28

Notice Regarding Dividend of Surplus

(184.6 KB)

Apr 28

Notice regarding Adjustment of Conversion Price for Zero Coupon Convertible Bonds due 2023 and 2025

(103.1 KB)

Apr 16

photonamic GmbH & Co. KG (Germany) Acquires Majority Stake in FerroSens GmbH.

(93.9 KB)

Mar 19

SBI Crypto announces start of its Mining Pool Service

(117.2 KB)

Mar 8

Start of Phase II Clinical Trial using 5-ALA by the University of Oxford and SBI Pharmaceuticals

(108.4 KB)

Mar 1

New Release of “Aladuck 405”, Bicolor LED Medical Light Source

(162.7 KB)

Feb 12

Subscription by Japannext Co., Ltd. to Third Party Allotment Capital Increase

(156.7 KB)

Feb 8

Notice of Establishment of Investment Company in Korea

(205.6 KB)

Jan 29

Notice of the Completion of Ripple's Investment in Money Tap Co., Ltd.

(172.5 KB)

Jan 14

Notice Regarding Case Reports on Treatment with 5-Aminolevulinic Acid Phosphate for Patients with New Coronavirus Infection (COVID-19)

(131.1 KB)

• 2020

Adobe Reader
You need to download Adobe Reader to view these PDF files.

• There is no charge for downloading Adobe Reader.
• The logos of Adobe Reader and Adobe Reader are the registered trademarks of Adobe Systems.